Citation:Videtic GM, Hu C, Singh AK, Chang JY, Parker W, Olivier KR, et al 2015

From Cancer Guidelines Wiki

Citation


Videtic GM, Hu C, Singh AK, Chang JY, Parker W, Olivier KR, et al. A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927). Int J Radiat Oncol Biol Phys 2015 Nov 15;93(4):757-64 Available from: http://www.ncbi.nlm.nih.gov/pubmed/26530743.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Videtic GM, Hu C, Singh AK, Chang JY, Parker W, Olivier KR, et al 2015What is the best practice radiotherapy approach in patients with stage I inoperable NSCLC?
What is the best practice radiotherapy approach in patients with stage II inoperable NSCLC?		Professor David Ball MB BS, MD, FRANCZRcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the best practice radiotherapy approach in patients with stage I inoperable NSCLC?, Clinical question:What is the best practice radiotherapy approach in patients with stage II inoperable NSCLC?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the best practice radiotherapy approach in patients with stage I inoperable NSCLC?</span>, <span class="smw-value">Clinical question:What is the best practice radiotherapy approach in patients with stage II inoperable NSCLC?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What is the best practice radiotherapy approach in patients with stage I inoperable NSCLC?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Videtic_GM,_Hu_C,_Singh_AK,_Chang_JY,_Parker_W,_Olivier_KR,_et_al_2015&oldid=118095"